Prostate Ca scientist wins Nobel Prize in chemistry

The Royal Swedish Academy of Sciences has awarded Aaron Ciechanover, MD, DSc, the 2004 Nobel Prize in chemistry.

Dr. Ciechanover, a scientist who receives funding from the Prostate Cancer Foundation, was recognized for his work on proteasome, a cellular machine that regulates the destruction of unneeded cell proteins. The proteasome is the target of the drug bortezomib (Velcade), which is being tested to treat prostate cancer and is approved to treat multiple myeloma.